Adefovir dipivoxil
Hepsera (adefovir dipivoxil) is a small molecule pharmaceutical. Adefovir dipivoxil was first approved as Hepsera on 2002-09-20. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b.
| Trade Name | Hepsera |
|---|---|
| Common Name | Adefovir dipivoxil |
| Indication | chronic hepatitis b, hepatitis b |
| Drug Class | Antivirals |
